ABIO Forecast and Technical Stock Analysis
Sell candidate since 2019-08-01 Loss -17.32%
ARCA biopharma fell by -6.91% in the last day ( Monday, 19th Aug 2019 ) from $5.64 to $5.25 During the day the stock fluctuated 8.38% from a day low at $5.25 to a day high of $5.69. The price has fallen in 6 of the last 10 days and is down by -19.72% for this period. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -175 413 shares and in total 55 663 shares bought and sold for approximately $292 231.00.
- 30 day high of the ABIO stock price was $7.17 and low was $5.25.
- 90 day high was $8.88 and low was $5.25.
- 52 week high for ARCA biopharma - $20.45 and low - $0.26.
ARCA biopharma lies in the lower of a very wide and falling trend in the short term, and this will normally pose a very good buying opportunity. A break down the bottom trend line at $4.95 will firstly indicate a stronger fall rate. Given the current short-term trend, the stock is expected to fall -12.35% during the next 3 months and, with 90% probability hold a price between $4.34 and $6.00 at the end of this period.
There are few to none technical positive signals at the moment. ARCA biopharma holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $5.75 and $6.57. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Tuesday August 13, 2019, which indicates further falls until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.
Relative Strength Index (RSI)
RSImin/max Values: [ 25 - 75 ]
RSI14 is 27 and the stock is currently not being overbought or oversold
* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.
Support & Resistance
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.44 between high and low, or 8.38%. For the last week the stock has had a daily average volatility of 8.37%.
Our recommended stop-loss: We hold a sell evaluation for this stock. No stop-loss set.
8.37 %Average volatility
Very Low Low Medium High Very High
ARCA biopharma holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Sell Candidate to a Strong Sell Candidate.
|ABIO $5.25 ($-0.39 -6.91%)|
ABIO is down $0.39 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for ABIO based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the ABIO analysis is free »
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!